[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. filed a Rule 144 notice reporting a proposed sale of 78,548 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $10,952,733.12 and an approximate sale date of 09/30/2025. The shares were acquired the same day as restricted stock units issued as compensation. The filing also discloses multiple Rule 10b5-1 sales by related parties totaling 247,365 shares over Aug–Sep 2025, which generated gross proceeds of $28,374,033.65.

Positive

• Compliance disclosure: The filer provided a Rule 144 notice with broker, share count, aggregate value, and sale date.
• Origin of shares disclosed: The 78,548 shares were acquired as restricted stock units (compensation) on 09/30/2025.
• Recorded 10b5-1 sales: Prior transactions are listed with dates, amounts, and gross proceeds, improving transparency.

Negative

• Substantial insider/affiliate sales: Six 10b5-1 transactions from Aug–Sep 2025 sold 247,365 shares for $28,374,033.65 in gross proceeds.
• Additional proposed sale: A planned sale of 78,548 shares valued at $10,952,733.12 on 09/30/2025 increases insider-related share supply to the market.

Insights

Securities Analyst

TL;DR: Insider-originated shares from RSUs are being sold; recent 10b5-1 sales show significant realized proceeds.

The filing documents a forthcoming sale of 78,548 Class A shares valued at $10.95 million, acquired as restricted stock units on the same date and presented for sale under Rule 144. The record of six 10b5-1 transactions by Michael Intrator and Omnadora Capital LLC between Aug and Sep 2025 shows 247,365 shares sold for $28.37 million in aggregate. For investors, this is clear disclosure of insider/affiliate liquidity activity rather than operational or financial performance information.

Corporate Governance Expert

TL;DR: Filing is a routine compliance disclosure showing compensation-origin shares and planned market sales; no undisclosed material information asserted.

The notice affirms the seller represents no undisclosed material adverse information and identifies the broker and sale timing. It also states acquisition was compensation via RSUs and lists prior 10b5-1 sales with dates and proceeds. This provides governance transparency on insider distribution of equity but does not address company operations or financial statements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	78548	10952733.12	370470348	09/30/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	09/30/2025	Acquired as compensation -- Restricted Stock Units	Issuer			78548	09/30/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for Michael Intrator 290 W Mt. Pleasant Avenue, Suite 4100 Livingston NJ 07039	Class A Common Stock	09/24/2025	32455	4223679.34
10b5-1 Sales for Omnadora Capital LLC 290 W Mt. Pleasant Avenue, Suite 4100 Livingston NJ 07039	Class A Common Stock	09/24/2025	50000	6506979.72
10b5-1 Sales for Michael Intrator 290 W Mt. Pleasant Avenue, Suite 4100 Livingston NJ 07039	Class A Common Stock	09/10/2025	32455	3840276.82
10b5-1 Sales for Omnadora Capital LLC 290 W Mt. Pleasant Avenue, Suite 4100 Livingston NJ 07039	Class A Common Stock	09/10/2025	50000	5916310.00
10b5-1 Sales for Michael Intrator 290 W Mt. Pleasant Avenue, Suite 4100 Livingston NJ 07039	Class A Common Stock	08/27/2025	32455	3104307.77
10b5-1 Sales for Omnadora Capital LLC 290 W Mt. Pleasant Avenue, Suite 4100 Livingston NJ 07039	Class A Common Stock	08/27/2025	50000	4782480.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for CRWV report?

The Form 144 reports a proposed sale of 78,548 Class A shares with an aggregate market value of $10,952,733.12, approximate sale date 09/30/2025, sold through Morgan Stanley Smith Barney.

How were the shares being sold acquired?

The filing states the 78,548 Class A shares were acquired as compensation (Restricted Stock Units) on 09/30/2025.

Were there recent insider sales disclosed in the filing for CRWV?

Yes. The filing lists six 10b5-1 sales between 08/27/2025 and 09/24/2025, totaling 247,365 shares and gross proceeds of $28,374,033.65.

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, 8th Floor, New York, NY.

Does the filer assert any undisclosed material information?

By signing the notice, the person represents they do not know any material adverse information